These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38979697)

  • 1. Research is needed to guide contingency management implementation across populations and settings.
    Rawson R; Khazanov GK; McKay JR
    Addiction; 2024 Sep; 119(9):1525-1526. PubMed ID: 38979697
    [No Abstract]   [Full Text] [Related]  

  • 2. Contingency management needs implementation science.
    Becker SJ
    Addiction; 2024 Sep; 119(9):1522-1524. PubMed ID: 38881151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should contingency management protocols and dissemination practices be modified to accommodate rising stimulant use and harm reduction frameworks?
    Khazanov GK; McKay JR; Rawson R
    Addiction; 2024 Sep; 119(9):1505-1514. PubMed ID: 38627885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contingency Management: New Directions and Remaining Challenges for An Evidence-Based Intervention.
    Rash CJ; Stitzer M; Weinstock J
    J Subst Abuse Treat; 2017 Jan; 72():10-18. PubMed ID: 27746057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contingency Management: Using Incentives to Improve Outcomes for Adolescent Substance Use Disorders.
    Stanger C; Budney AJ
    Pediatr Clin North Am; 2019 Dec; 66(6):1183-1192. PubMed ID: 31679606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How patient navigators view the use of financial incentives to influence study involvement, substance use, and HIV treatment.
    Mitchell SG; Monico LB; Stitzer M; Matheson T; Sorensen JL; Feaster DJ; Schwartz RP; Metsch L
    J Subst Abuse Treat; 2018 Nov; 94():18-23. PubMed ID: 30243412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Closing the research-to-implementation gap for contingency management as an effective intervention for substance use disorders across diverse communities.
    Hirchak K
    Addiction; 2024 Sep; 119(9):1519-1521. PubMed ID: 38770791
    [No Abstract]   [Full Text] [Related]  

  • 8. The dissemination and implementation of contingency management for substance use disorders: A systematic review.
    Oluwoye O; Kriegel L; Alcover KC; McPherson S; McDonell MG; Roll JM
    Psychol Addict Behav; 2020 Feb; 34(1):99-110. PubMed ID: 31259569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtual contingency management, what is it worth and who will pay for it?
    McKetin R; Clay S
    Addiction; 2024 Sep; 119(9):1517-1518. PubMed ID: 38752258
    [No Abstract]   [Full Text] [Related]  

  • 10. Contingency Management for Stimulant Use Disorder: Progress, Challenges, and Recommendations.
    Rawson RA; Erath TG; Chalk M; Clark HW; McDaid C; Wattenberg SA; Roll JM; McDonell MG; Parent S; Freese TE
    J Ambul Care Manage; 2023 Apr-Jun 01; 46(2):152-159. PubMed ID: 36745163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mobile telephone-delivered contingency management interventions promoting behaviour change in individuals with substance use disorders: a meta-analysis.
    Getty CA; Morande A; Lynskey M; Weaver T; Metrebian N
    Addiction; 2019 Nov; 114(11):1915-1925. PubMed ID: 31265747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contingency management interventions for HIV-related behaviors.
    Haug NA; Sorensen JL
    Curr HIV/AIDS Rep; 2006 Nov; 3(4):154-9. PubMed ID: 17032574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contingency management treatments: controversies and challenges.
    Petry NM
    Addiction; 2010 Sep; 105(9):1507-9. PubMed ID: 20707772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contingency management for treatment of substance abuse.
    Stitzer M; Petry N
    Annu Rev Clin Psychol; 2006; 2():411-34. PubMed ID: 17716077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations for remote delivery of behavioral economic interventions for substance use disorder during COVID-19 and beyond.
    Coughlin LN; Bonar EE; Bickel WK
    J Subst Abuse Treat; 2021 Jan; 120():108150. PubMed ID: 33298296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counselor Attitudes Toward Contingency Management for Substance Use Disorder: Effectiveness, Acceptability, and Endorsement of Incentives for Treatment Attendance and Abstinence.
    Aletraris L; Shelton JS; Roman PM
    J Subst Abuse Treat; 2015 Oct; 57():41-8. PubMed ID: 26001821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contingency management interventions: from research to practice.
    Petry NM; Petrakis I; Trevisan L; Wiredu G; Boutros NN; Martin B; Kosten TR
    Am J Psychiatry; 2001 May; 158(5):694-702. PubMed ID: 11329388
    [No Abstract]   [Full Text] [Related]  

  • 18. Motivation and Contingency Management Treatments for Substance Use Disorders.
    Walter KN; Petry NM
    Curr Top Behav Neurosci; 2016; 27():569-81. PubMed ID: 25762429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of behavioral contingency management in drug abuse treatment.
    Bigelow GE; Stitzer ML; Liebson IA
    NIDA Res Monogr; 1984; 46():36-52. PubMed ID: 6427623
    [No Abstract]   [Full Text] [Related]  

  • 20. Patients' beliefs towards contingency management: Target behaviours, incentives and the remote application of these interventions.
    Getty CA; Weaver T; Lynskey M; Kirby KC; Dallery J; Metrebian N
    Drug Alcohol Rev; 2022 Jan; 41(1):96-105. PubMed ID: 34034358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.